Tuberculosis prophylaxis in the immunosuppressed subject;La prophylaxie de la tuberculose chez le sujet immunodeprime

Annales de Medecine Interne

Volumn 148, Issue 3, 1997, Pages 226-229

  Perronne, Christian ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Chemoprophylaxis; Immunosuppression; Tuberculosis

Indexed keywords

CORTICOSTEROID; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULIN;

CHEMOPROPHYLAXIS; DRUG ANTAGONISM; DRUG EFFICACY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; REVIEW; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; HUMANS; IMMUNOCOMPROMISED HOST; TIME FACTORS; TUBERCULOSIS;

EID: 0030741076     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. AMERICAN THORACIC SOCIETY : Treatment of tuberculosis infection in adults and children. Am J Respir Crit Care Med. 1994 ; 149 : 1359-74.
2. GROSSET JH : Present status of chemotherapy for tuberculosis. Rev Infect Dis 1989 ; 11 (Suppl. 2 ) : S 347-52.
3. MENZIES R, VISSANDJEE B : Effect of bacille Calmette-Gué-rin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992 ; 145 : 621-5.
4. MARKOWITZ N, HANSEN NI, WILCOSKY TC et al : Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann Intern Med 1993 ; 119 : 185-93.
5. PERRONNE C, WALCKENAER G, DELAGNES M et al : Prevalence of positivity of tuberculin skin test reactions among 1249 HIV-infected patients in France. 9th International Conference on AIDS, Berlin, Allemagne, Juin 1993. Abstract PO-B07-1152.
6. MORENO S, BARAIA-ETXABURU J, BOUZA et al : Risk of developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993 ; 119 : 194-8.
7. GUELAR A, GATELL JM, VERDEJO J et al : A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 1993 ; 7 : 1345-9.
8. ALCABES P, VOSSENAS P, COHEN R, BRASLOW C, MI-CHAELS D, ZOLOTH S : Compliance with isoniazid prophylaxis in jail. Am Rev Respir Dis 1989 ; 140 : 1194-7.
9. KOPANOFF DE, SNIDER DE Jr, CARAS GJ : Isoniazid related hepatitis. A US Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978 ; 117 : 991-1001.
10. ALTMAN C, BIOUR M, GRANGE JD : Toxicité hépatique des antituberculeux. Rôle des différents médicaments. 199 observations. Presse Méd 1993 ; 22 : 1212-6.
11. HONG KONG CHEST SERVICE, TUBERCULOSIS RESEARCH CENTRE, MADRAS, BRITISH MEDICAL RESEARCH COUNCIL. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 1992 ; 145 : 36-41.
12. PAPE JW, JEAN SS, HO JL, HAFNER A, JONHSON WD Jr. : Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet, 1993 ; 342 : 268-72.
13. HALSEY N, COBERLY J, ATKINSON J, BOULOS R et al : Twice weekly INH for TB prophylaxis. 10th International Conference on AIDS, Yokohama, Japon, août 1994. Abstract PB0681.
14. PERRONNE C, VINCENT V : Rifamycines. Encycl Méd Chir (Elsevier, Paris), Maladies infectieuses, 8-004-K-10, 1995, 5 p.
15. HORN DL, HEWLETT D Jr, ALFALLA C, PETERSON S : Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis. N Engl J Med 1994 ; 330 : 1241.